SYK250117C390000
- 0.01
- 0.000.00%
Stryker Corp Newsroom
Live Stock News: Market Climbs, Crypto Falls, Big Tech is Here and Trump Starts Signing Orders
A Look At The Fair Value Of Stryker Corporation (NYSE:SYK)
Germany Operating Room Integration Systems Market Outlook to 2033, Competitive Analysis of Steris, Getinge, Olympus, Hill-Rom, Stryker Corp
Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
How Is The Market Feeling About Stryker?
Wall Street Today: Thursday Earnings Looked a Lot More Mixed, and Philly is Booming
Live Stock News: Sideways Trading Market After Big TSMC, UNH Earnings, Philly Economy is Booming
Wall Street Today: JPM and Banking Leads Market Higher
Live Stock: Banks Break the Bank on Earnings, Inflation Looks Tame for Dec
Wall Street Today: Market Barely Climbs, Wholesale Inflation Grows Less Than Feared
Needham's Top Stocks for 2025: AX, CYBR, CART and More
Live Stock News: Tuesday Market Climbs and TikTok Sale Might be Incoming
Wall Street Today: Market Turns Around, Let's See if it Lasts
Live Stock News: Monday Market Falling, 'Too Big to Fail' Earnings to Start Q1 Report Season
Here's Why Jim Cramer Is Excited About Stryker (SYK) Expanding Beyond Surgical Robotics
Johnson & Johnson (JNJ.US) is negotiating to acquire the $10 billion market cap biotech star Intra-Cellular, and the medical merger wave is surging again!
Johnson & Johnson is in talks to acquire the biopharmaceutical company Intra-Cellular Therapies Inc., which focuses on treating central nervous system diseases, and both parties may reach an agreement as early as this week.